Hansoh Pharmaceutical Group Company Limited

HKEX:3692.HK

17.7 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016
Assets:
Current Assets:
Cash & Cash Equivalents 22,434.69117,615.27414,702.0564,284.978,238.4221,098.374319.93233.076
Short Term Investments 2,422.3751,470.8891,882.2289,241.293,588.197586.6631,042.967979.737
Cash and Short Term Investments 24,857.06621,630.58918,941.49913,726.2614,598.6593,980.5742,092.6141,512.482
Net Receivables 3,214.2513,578.3923,675.993,127.462,245.9593,079.5632,681.8811,958.841
Inventory 575.782447.89410.127298.727414.348546.055527.551394.289
Other Current Assets 748.6172,719.1752,508.967333.5422,961.0723.1582.6672.667
Total Current Assets 28,883.30725,831.6223,179.36817,285.98917,447.9987,609.355,304.7133,868.279
Non-Current Assets:
Property, Plant & Equipment, Net 3,293.653,449.8933,475.3952,303.8181,927.9321,573.0851,406.6561,170.507
Goodwill 00000000
Intangible Assets 177.41633.42217.0379.8934.56811.92511.026.769
Goodwill and Intangible Assets 177.41633.42217.0379.8934.56811.92511.026.769
Long Term Investments 684.706653.65394.96728.3890000
Tax Assets -13.9270000000
Other Non-Current Assets 13.927-4,136.965-3,887.399-2,342.1-1,932.5-1,585.01-1,417.676-1,177.276
Total Non-Current Assets 4,155.7724,136.9653,887.3992,342.11,932.51,585.011,417.6761,177.276
Total Assets 33,039.07930,001.87927,160.17120,792.0619,575.2048,414.3715,874.0484,820.951
Liabilities & Equity:
Current Liabilities:
Account Payables 163.763222.296248.33124.382192.85180.791118.62650.154
Short Term Debt 4,199.28515.5439.96811.0393.653000
Tax Payables 227.201151.066247.057119.803104.559123.073267.377198.064
Deferred Revenue -16.087-15.543-9.968-11.039-3.653000
Other Current Liabilities 2,515.8882,397.2062,775.42,565.1576,047.4824,946.3671,355.4921,973.459
Total Current Liabilities 6,862.8492,619.5023,023.732,689.5396,240.3325,127.1581,474.1182,023.612
Non-Current Liabilities:
Long Term Debt 104.454,282.7423,742.99681.715.783000
Deferred Revenue Non-Current 03,932.0813,476.2440-284.767000
Deferred Tax Liabilities Non-Current 255.02350.661266.752121.81284.767242.688127.68434.649
Other Non-Current Liabilities 21.987-4,282.742-3,742.99623.403284.767-242.68800
Total Non-Current Liabilities 381.4574,282.7423,742.996226.923290.5561.897127.68434.649
Total Liabilities 7,244.3067,354.9357,131.3262,916.4626,530.8826,769.531,627.4342,062.308
Equity:
Preferred Stock 036.912846.923710.99202,084.9384,556.1122,382.945
Common Stock 0.0520.0520.0520.0520.0510.0010.0010.001
Retained Earnings 10,506.3648,780.296,909.8084,577.7722,008.8651,311.5893,901.2971,846.752
Accumulated Other Comprehensive Income/Loss 25,903.35-36.912-846.923-710.992198.612-773.347-654.814-536.191
Other Total Stockholders Equity -10,614.99313,866.60213,118.98513,297.77410,836.794-1,311.591-3,901.298-1,846.754
Total Shareholders Equity 25,794.77322,646.94420,028.84517,875.59813,044.3221,311.5913,901.2981,846.754
Total Equity 25,794.77322,646.94420,028.84517,875.59813,044.3221,311.5913,901.2981,846.754
Total Liabilities & Shareholders Equity 33,039.07930,001.87927,160.17120,792.0619,575.2048,414.3715,874.0484,820.951